More than 200 different COVID-19 vaccines are currently under production around the world.
Sputnik V is the world’s first registered vaccine based on a well-studied human adenoviral vector-based platform. It currently ranks on the World Health Organization (WHO) list among the top-10 candidate vaccines approaching the end of clinical trials and the start of mass production.
40,000 participants are interested in the ongoing Sputnik V post-registration clinical trial in Russia.
In the UAE, India, Venezuela and Belarus, clinical trials have been announced for Sputnik V.